ASND offering history
Every offering-related filing in Ascendis Pharma A/S’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 777 filings back to Aug 1, 2014.
| Date | Filing | What it means | |
|---|---|---|---|
| Sep 20, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 18, 2024 | F-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Sep 18, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 2, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 31, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 27, 2021 | F-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Jul 9, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 6, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 6, 2019 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 4, 2019 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 8, 2019 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 30, 2018 | F-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Feb 23, 2018 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 21, 2018 | F-3MEF → | REGISTERED | F-3MEF registration — capacity to sell shares, not a sale yet |
| Feb 20, 2018 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 28, 2017 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 26, 2017 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 23, 2017 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 5, 2017 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 22, 2017 | F-3 → | REGISTERED | F-3 registration — capacity to sell shares, not a sale yet |
| Oct 19, 2016 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Oct 18, 2016 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 2, 2016 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 20, 2016 | F-3 → | REGISTERED | F-3 registration — capacity to sell shares, not a sale yet |
| Feb 17, 2016 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Feb 2, 2016 | F-3 → | REGISTERED | F-3 registration — capacity to sell shares, not a sale yet |
| Jan 28, 2015 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jan 27, 2015 | F-1MEF → | REGISTERED | F-1MEF registration — capacity to sell shares, not a sale yet |
| Jan 27, 2015 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 27, 2015 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 26, 2015 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Jan 26, 2015 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Jan 16, 2015 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| Dec 18, 2014 | F-1 → | REGISTERED | F-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
ASND offering FAQ
When did ASND last execute an offering?
Per SEC filings, Ascendis Pharma A/S's most recent priced offering document is a 424B5 filed 2024-09-20. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did ASND last announce or register an offering?
The most recent registration is a F-3ASR filed 2024-09-18. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.